Richard Wooster
Impact in
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.5%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
- Bioinformatics and Genomic Networks 3
- Genomics and Chromatin Dynamics 3
-
- Cancer Genomics and Diagnostics 5
- Co-authors
- Omid C. Farokhzad (1 shared paper)Jinjun Shi (1 shared paper)Philip W. Kantoff (1 shared paper)Junping Jing (5 shared papers)Kurtis E. Bachman (4 shared papers)A. Pieter J. van den Heuvel (1 shared paper)Joel Greshock (8 shared papers)Robert te Poele (1 shared paper)
- Journals
- Cancer Research (7 papers)Molecular Cancer Therapeutics (6 papers)Trends in Genetics (2 papers)International Journal of Cancer (2 papers)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Richard Wooster
29 papers receiving 6.1k citations
Richard Wooster's Hit Papers
Peers
Comparison fields: 5 of 131
- Biomaterials 2.5k
- Biomedical Engineering 2.9k
- Cancer Research 539
- Molecular Biology 2.5k
- Oncology 767
Countries citing papers authored by Richard Wooster
This map shows the geographic impact of Richard Wooster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Wooster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Wooster more than expected).
Fields of papers citing papers by Richard Wooster
This network shows the impact of papers produced by Richard Wooster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Wooster. The network helps show where Richard Wooster may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard Wooster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer nanomedicine: progress, challenges and opportunities Hit paper breakdown → | 2016 | 4679 |
| 2 | 2009 | 284 | |
| 3 | 2012 | 176 | |
| 4 | 2001 | 139 | |
| 5 | 2000 | 126 | |
| 6 | 2010 | 100 | |
| 7 | 2011 | 97 | |
| 8 | 2011 | 89 | |
| 9 | 2010 | 75 | |
| 10 | 2019 | 55 | |
| 11 | 2009 | 46 | |
| 12 | 2010 | 41 | |
| 13 | 2019 | 41 | |
| 14 | 2012 | 27 | |
| 15 | 2000 | 20 | |
| 16 | 1995 | 20 | |
| 17 | 2008 | 18 | |
| 18 | 2002 | 18 | |
| 19 | 2012 | 16 | |
| 20 | 2011 | 14 |
About Richard Wooster
Richard Wooster is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 6.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Microtubule and mitosis dynamics (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Neuroblastoma Research and Treatments (3 papers), Lung Cancer Research Studies (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Bioinformatics and Genomic Networks (3 papers) and Genomics and Chromatin Dynamics (3 papers). The work is most often cited by research in Biomaterials (2.5k citations), Biomedical Engineering (2.9k citations), Cancer Research (539 citations), Molecular Biology (2.5k citations) and Oncology (767 citations). Richard Wooster has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Omid C. Farokhzad, Jinjun Shi, Philip W. Kantoff, Junping Jing, Kurtis E. Bachman, A. Pieter J. van den Heuvel, Joel Greshock, Robert te Poele, Paul A. Clarke and Paul Workman. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Trends in Genetics, International Journal of Cancer and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.